Creative Medical Technology Holdings, Inc. (CELZ): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$10.72M
As of 2021-12-31
+227.9%
3-year compound annual growth
+117.2%
5-year compound annual growth
n/m
10-year compound annual growth
2010-12-31: $4142011-12-31: $1.1K2012-12-03: $7812012-12-31: $7812013-12-31: $3742014-12-31: $9542015-12-31: $2162016-12-31: $221.9K2017-12-31: $13.7K2018-12-31: $304.1K2019-12-31: $88.6K2020-12-31: $98.0K2021-12-31: $10.72M$10.72M
2010-12-31 Cash & Equivalents (USD) 2021-12-31
Period endedCash & EquivalentsChange YoYSource filing
2021-12-31$10.72Mn/m2022-03-30, Balance as of period end
2020-12-31$98.0K+10.6%2022-03-30, Balance as of period end
2019-12-31$88.6K-70.8%2021-03-17, Balance as of period end
2018-12-31$304.1Kn/m2020-04-06, Balance as of period end
2017-12-31$13.7K-93.8%2019-04-01, Balance as of period end
2016-12-31$221.9Kn/m2018-03-29, Balance as of period end
2015-12-31$216-77.4%2016-04-14, Balance as of period end
2014-12-31$954+155.1%2016-04-14, Balance as of period end
2013-12-31$374-52.1%2015-02-27, Balance as of period end
2012-12-31$781n/a2014-03-17, Balance as of period end
2012-12-03$781n/a2013-03-15, Balance as of period end
2011-12-31$1.1K+166.9%2013-03-15, Balance as of period end
2010-12-31$414n/a2012-03-26, Balance as of period end